11.16.21
The treatment landscape for nAMD has expanded to include a refillable, intraocular device that continuously delivers therapy. What was the inspiration behind this new treatment approach? John Kitchens, MD is joined by inventor Eugene de Juan, MD and physician-scientist Tony Adamis, MD to discuss the device and the innovative technology behind its development. During this podcast, they reflect on how their careers and contributions from others in the field led to the drug delivery system. This special episode of New Retina Radio is supported by Genentech USA, Inc., which is responsible for its content.
View full description +
Subscribe
09.04.25
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDRDavid Lally, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Genentech
08.21.25
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human GradersJohn Kitchens, MD; Krishna Mukkamala, MD
Editorially independent content, supported by Genentech
07.21.25
The State of Geographic Atrophy Around the Globe: Part 2 of 2Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD
Editorially independent content, supported by Astellas
07.21.25
The State of Geographic Atrophy Around the Globe: Part 1 of 2Anat Loewenstein, MD; Paulo Eduardo Stanga, MD; Patricio G. Schlottmann, MD; Daniel Ting, MD, PhD
Editorially independent content, supported by Astellas
07.18.25
Diabetic Retinopathy Severity and Income StatusBen Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD
Editorially Independent Supported By Genentech and Neurotech.
07.07.25
GA in 2025: Conversion to Wet AMD and Educating Patients on the Value of Continuing TherapyJudy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
Editorially independent content, supported by Apellis
07.07.25
GA in 2025: Dosing Regimens, Drug Selection, and Ideal CandidatesJudy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
Editorially independent content, supported by Apellis
Show More